State Street Corp Imago Bio Sciences, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $36.01 $0 - $17.2 Million	-476,648 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $1.23 Million - $2.95 Million	82,009 Added 20.78%	476,648 $17.1 Million
Q3 2022 Nov 15, 2022	BUY	$14.15 - $19.5 $649,584 - $895,186	45,907 Added 13.16%	394,639 $5.94 Million
Q2 2022 Aug 15, 2022	BUY	$11.81 - $20.92 $1.06 Million - $1.88 Million	89,901 Added 34.73%	348,732 $4.67 Million
Q1 2022 May 16, 2022	BUY	$16.97 - $25.0 $1.83 Million - $2.7 Million	108,040 Added 71.65%	258,831 $4.99 Million
Q4 2021 Feb 14, 2022	BUY	$16.22 - $29.69 $667,793 - $1.22 Million	41,171 Added 37.56%	150,791 $3.58 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $1.75 Million - $3.16 Million	109,620 New	109,620 $2.2 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.